Live IPO - Uniti Wireless Ltd.

/
uniti-wireless-logo.jpg

Uniti Wireless Ltd (ASX: UWL) is a fixed wireless broadband provider with proven high speed performance with the potential to provide an alternative solution to the nbn™ on a national scale.

It is currently operational in suburban metropolitan Adelaide and areas of suburban Melbourne connecting residential, business and enterprise customer premises to its independent ‘last mile’ network. As a replacement for ADSL Internet and nbn™ services, it operates its network independently and does not rely on Telstra’s ADSL copper network or the nbn™ infrastructure to operate or reach its customers.

The Company has executed a share sale and purchase agreement to acquire FuzeNet.  FuzeNet was incepted in 2007 and operates the business of a retail service provider (RSP). FuzeNet’s major fibre access provider has an additional 90 buildings under construction for CY2019 – a 39% increase over the current building portfolio for their core product and further expanding the Uniti Wireless network/tower capability.

The combination of both businesses is highly complementary in that FuzeNet has access to over 200 on-net buildings (towers) – almost tripling the potential of the current Uniti network of 113 towers.

  • Pay by: 14 January 19

  • List Price: $0.20

  • Minimum Investment: $2,000

  • Maximum Investment: $10,000

  • Prospectus

Closed

Live IPO - HeraMED Limited.

/
hera med.png

HeraMED (ASX:HMD) was incorporated in 2011 in Israel as a technology start-up developing innovative, connected pregnancy monitoring solutions.Its first commercial product, HeraBEAT™ is a medical-grade, clinically validated fetal heart rate monitor mainly for home use.

Today, fetal heart monitoring is a standard part of every pregnancy check-up, but current technologies are expensive, bulky, limited and designed for professional use only. The result is that pregnancy monitoring almost always requires a clinical setting, a nurse or doctor to conduct the measurement and the careful attention of a trained obstetrician-gynaecologist for a subjective, time-consuming, visual interpretation of FHR pattern recognition and assessment.

HeraMED’s aim is to become a world leader in innovative, accessible, technology-driven products which change the way practitioners and expectant mothers approach and monitor the miracle of pregnancy.

  • Pay by: 2 November 18

  • List Price: $0.20

  • Minimum Investment: $2,000

  • Maximum Investment: $5,000

  • Prospectus

Closed.

Live IPO - AXS Group Ltd.

/
AXS.jpg

AXS Group Limited (ASX Code: AXS) is a global software provider of hosted, SaaS and cloud-based solutions to clients in the financial services and operates an end-to-end process architecture for clients in the wealth management sector.  The company has a track record of successfully tendering and integrating businesses into its ARMnet software with approximately over 75 third party systems integrations performed for clients with varying customised solutions found. The ARMnet platform uses cognitive processes, including robotic process automation and blockchain techniques to give real time output, reducing time and cutting costs.

AXS provides its clients with a digital transformation through its internally owned and developed software platform, ARMnet. The ARMnet platform is a customer relationship management (CRM) financial product management solution that is built on an industry standard Microsoft dot.net framework. It enables clients to improve business efficiency, productivity and accountability, while lowering the costs and risks in delivering different kinds of financial services solutions. 

On completion of the IPO, AXS Group will complete the acquisition of Axcess Consulting Group Pty Ltd the operating entity, which is a global integrated software solution provider to the finance, insurance and funds sectors and has grown organically and operated for over 13 years.

  • Opened: 11 October 18

  • Pay by: March 6, 2019

  • List Price: $0.25

  • Minimum Investment: $2,000

  • Prospectus

Closed.

Live IPO - Nanoveu Ltd.

/
nanoveu.jpg

Nanoveu Limited (ASX: NVU) aims to become a market leading technology company by applying nanotechnology to deliver vision shaping applications to digital screens. Nanoveu’s award-winning product, EyeFly3DTM, uses a combination of software (application) and hardware (screen protector) to offer real time, affordable and easy to use 3D rendering and 2D-to-3D instant conversion of videos and photos on smartphones and tablets – without the use of 3D glasses..

Nanoveu is also developing its complementary EyeFyx technology through its ongoing research and development program. Using the EyeFyx technology (which comprises a combination of hardware and software), the Company is working towards developing a product which aims to correct images for certain vision aberrations on high resolution digital devices, such as smartphones and tablets.

  • Opened: 26 September 18

  • Pay by: 2 November 18

  • List Price: $0.20

  • Minimum Investment: $2,000

  • Prospectus

Closed.